BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15848464)

  • 1. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.
    Buell JF; Gross T; Alloway RR; Trofe J; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):583-4. PubMed ID: 15848464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of donor cancer into cardiothoracic transplant recipients.
    Buell JF; Trofe J; Hanaway MJ; Lo A; Rosengard B; Rilo H; Alloway R; Beebe T; First MR; Woodle ES
    Surgery; 2001 Oct; 130(4):660-6; discussion 666-8. PubMed ID: 11602897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver grafts from donors with central nervous system tumors: a single-center perspective.
    Kashyap R; Ryan C; Sharma R; Maloo MK; Safadjou S; Graham M; Tretheway D; Jain A; Orloff M
    Liver Transpl; 2009 Oct; 15(10):1204-8. PubMed ID: 19790151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should lung transplantation be performed using donation after cardiac death? The United States experience.
    Mason DP; Thuita L; Alster JM; Murthy SC; Budev MM; Mehta AC; Pettersson GB; Blackstone EH
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1061-6. PubMed ID: 18954650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donors with central nervous system malignancies: are they truly safe?
    Buell JF; Trofe J; Sethuraman G; Hanaway MJ; Beebe TM; Gross TG; Alloway R; First MR; Woodle ES
    Transplantation; 2003 Jul; 76(2):340-3. PubMed ID: 12883189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population.
    Buell JF; Papaconstantinou HT; Skalow B; Hanaway MJ; Alloway RR; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):960-1. PubMed ID: 15848590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience.
    Woodle ES; Gupta M; Buell JF; Neff GW; Gross TG; First MR; Hanaway MJ; Trofe J
    Transplant Proc; 2005 Mar; 37(2):958-9. PubMed ID: 15848589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry.
    Desai R; Collett D; Watson CJ; Johnson P; Evans T; Neuberger J
    Br J Surg; 2014 Jun; 101(7):768-74. PubMed ID: 24771410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience.
    De Perrot M; Waddell TK; Shargall Y; Pierre AF; Fadel E; Uy K; Chaparro C; Hutcheon M; Singer LG; Keshavjee S
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):525-31. PubMed ID: 17258592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of an undiagnosed sarcoma to recipients of kidney and liver grafts procured in a non-heart beating donor.
    Detry O; De Roover A; de Leval L; Herens C; Delwaide J; Honoré P; Meurisse M
    Liver Transpl; 2005 Jun; 11(6):696-9. PubMed ID: 15915495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor kidneys with small renal cell cancers: can they be transplanted?
    Buell JF; Hanaway MJ; Thomas M; Munda R; Alloway RR; First MR; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):581-2. PubMed ID: 15848463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spanish National Transplant Organization (ONT) tumor registry.
    Garrido G; Matesanz R
    Transplantation; 2008 Apr; 85(8 Suppl):S61-3. PubMed ID: 18425039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
    Selck FW; Grossman EB; Ratner LE; Renz JF
    Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M
    Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advising potential recipients on the use of organs from donors with primary central nervous system tumors.
    Warrens AN; Birch R; Collett D; Daraktchiev M; Dark JH; Galea G; Gronow K; Neuberger J; Hilton D; Whittle IR; Watson CJ;
    Transplantation; 2012 Feb; 93(4):348-53. PubMed ID: 22258288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
    Lee KW; Simpkins CE; Montgomery RA; Locke JE; Segev DL; Maley WR
    Transplantation; 2006 Dec; 82(12):1683-8. PubMed ID: 17198260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update.
    Kauffman HM; Cherikh WS; McBride MA; Cheng Y; Hanto DW
    Transplantation; 2007 Jul; 84(2):272-4. PubMed ID: 17667822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
    Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is third-time heart retransplantation justifiable?
    Odim J; Banerji A; Bahrami S; Laks H
    Transplant Proc; 2006 Jun; 38(5):1516-9. PubMed ID: 16797347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donors older than 70 years in liver transplantation.
    Gastaca M; Valdivieso A; Pijoan J; Errazti G; Hernandez M; Gonzalez J; Fernandez J; Matarranz A; Montejo M; Ventoso A; Martinez G; Fernandez M; de Urbina JO
    Transplant Proc; 2005 Nov; 37(9):3851-4. PubMed ID: 16386560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.